| Literature DB >> 30880808 |
Alex Fauer1, Christopher R Friese1.
Abstract
The 340B Drug Pricing Program is a complex federal program that is intended to provide financial relief to hospitals that provide care to greater volumes of low-income, uninsured, and underinsured patients. The body of literature is growing on how cancer care has transformed since freestanding cancer hospitals became eligible for the 340B program. Currently, community oncology practices are not eligible for the 340B program.Entities:
Keywords: antineoplastic agents; health policy; oncology nursing; outpatient clinics
Mesh：
Substances：
Year: 2019 PMID： 30880808 DOI： 10.1188/19.CJON.217-219
Source DB: PubMed Journal: Clin J Oncol Nurs ISSN： 1092-1095 Impact factor: 1.027